Daniel Cruz Galarza, MD - Medicare in Ponce, PR

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

News Archive

Minn. Gov. decides to not expand Medicaid early; Ohio wrestles with increased Medicaid costs in overhaul; Kansas officials worry about 25% cut in health policy operating budget

"As expected, Gov. Tim Pawlenty has declined the opportunity for Minnesota to get an early shot at expanding Medicaid eligibility. The federal health plan calls for all states to expand Medicaid eligibility to low-income adults without children in 2014, but Minnesota was among a few states offered a chance to do it earlier." The legislature, however, passed a measure that would allow Pawlenty's successor next year to reverse his ruling (Kimball, 6/22).

Research establishes bases of possible future pharmaceutical drugs to combat AIDS virus

The doors are closing on the AIDS virus. The scientific community continues to strive to find the formula that will halt the advance of one of the viruses that has sparked most scientific interest over recent years. A study by the Consejo Superior de Investigaciones Cient-ficas (CSIC) and led by Mr F-lix Go-i, director of the Biophysics Unit at the CSIC-University of the Basque Country Mixed Centre, has developed a method of attack against the AIDS virus The method involves creating a prevention system, i.e. an 'armour' in the cells that are likely to be infected and thus impede, de facto, the virus from accessing them and starting to act on their immunological system.

3M granted FDA approval for cream to treat superficial basal cell carcinoma

3M announced today that the U.S. Food and Drug Administration (FDA) has approved the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma (sBCC), a type of nonmelanoma skin cancer.

Study shows half of adolescents misuse their prescription drugs

Although prescription drug misuse is on the decline among adolescents, one in two patients tested between the ages of 10 and 17 years are not using their medications appropriately, potentially putting their health at risk, according to an analysis by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services.

Novel combination of cancer drugs can have therapeutic impact on diffuse large B-cell lymphoma

New research from Roswell Park Cancer Institute shows that promising cancer drugs used in combination can have significant therapeutic impact on a particularly aggressive subtype of diffuse large B-cell lymphoma (DH-DLBCL) in preclinical studies. The researchers will present their findings at the American Association for Cancer Research (AACR) Annual Meeting 2016, to be held April 16-20 in New Orleans.

Read more News

› Verified 4 days ago